These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36661350)

  • 1. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
    Ba ZC; Zhang HX; Liu AY; Zhou XX; Liu L; Wang XY; Nanding A; Sang XQ; Kuai ZX
    Clin Breast Cancer; 2024 Jul; 24(5):e417-e427. PubMed ID: 38555225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
    Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Sep; 34(9):6132-6144. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
    Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
    J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer.
    Zhang L; Shen M; Zhang D; He X; Du Q; Liu N; Huang X
    J Magn Reson Imaging; 2024 Sep; 60(3):1203-1212. PubMed ID: 38088478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Lymphovascular Invasion in Breast Cancer Using a Combined MRI Morphological Features, Radiomics, and Deep Learning Approach Based on Dynamic Contrast-Enhanced MRI.
    Yang X; Fan X; Lin S; Zhou Y; Liu H; Wang X; Zuo Z; Zeng Y
    J Magn Reson Imaging; 2024 Jun; 59(6):2238-2249. PubMed ID: 37855421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
    Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
    Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-Based Radiomics.
    Bian T; Wu Z; Lin Q; Mao Y; Wang H; Chen J; Chen Q; Fu G; Cui C; Su X
    J Magn Reson Imaging; 2022 Mar; 55(3):772-784. PubMed ID: 34453461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
    Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
    Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.
    Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment Multiparametric MRI-Based Radiomics Analysis for the Diagnosis of Breast Phyllodes Tumors.
    Ma X; Gong J; Hu F; Tang W; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Feb; 57(2):633-645. PubMed ID: 35657093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
    Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
    Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.